ENCORE ENA COMBINED EIA

Extractable Antinuclear Antibody, Antigen And Control

CLARK LABORATORIES, INC.

The following data is part of a premarket notification filed by Clark Laboratories, Inc. with the FDA for Encore Ena Combined Eia.

Pre-market Notification Details

Device IDK931543
510k NumberK931543
Device Name:ENCORE ENA COMBINED EIA
ClassificationExtractable Antinuclear Antibody, Antigen And Control
Applicant CLARK LABORATORIES, INC. 53 CEDAR LAKE RD. Blairstown,  NJ  07825
ContactGary Lehnus
CorrespondentGary Lehnus
CLARK LABORATORIES, INC. 53 CEDAR LAKE RD. Blairstown,  NJ  07825
Product CodeLLL  
CFR Regulation Number866.5100 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1993-03-29
Decision Date1993-09-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.